This patent covers composition of matter on a factor, which seems to be not clearly stated, that can induce both proliferation and differentiation of hematopoietic stem cells, as well as stem cells that have been committed to the lymphoid lineage. This patent is particularly useful for treatment of patients after bone marrow transplantation, or chemotherapy, or radiation therapy.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.